Six Pioneering Companies Shaping the Future of Medical Wearables File IPO Prospectuses

With the continuous advancement of technology, the development of wearable devices is accelerating. BeBop Sensors, winner of the “Frost & Sullivan 2015 North America New Product Innovation Award,” has pioneered the development of a fabric embedded with sensors. These integrated sensors can measure force, position, size, and weight; recognize shapes; capture movements; and detect the presence of humans and objects.

The company’s sensor products are applicable not only to the wearable device industry but also to the automotive, manufacturing, sports, and healthcare sectors. Within the healthcare sector alone, the fabrics produced by the company serve multiple purposes. For instance, they are used to make hospital bed sheets that provide physiological data about patients when they lie on them. These fabrics can also be integrated into chairs to collect data and alert users to correct their sitting posture.

This embedded chip architecture technology was launched last year and has garnered support from instrument inventor Keith McMillen.

Moreover, BeBop Sensors is just one of the companies currently shaping the future of wearable medical devices. Here are five others; let’s take a brief look.

JUNE Bracelet
The company’s wearable medical wristband features a built-in ultraviolet (UV) sensor that tracks and measures the user’s sun exposure, transmitting the relevant data to its corresponding iOS application. The app informs users of the received UV radiation intensity and, based on this data, determines whether sunscreen application or sunglasses are necessary, providing tailored recommendations accordingly. To obtain precise data for personalized advice, users are required to complete a questionnaire regarding their physiological characteristics, including questions about skin tone and eye color.

Motus Global
This sports biomechanics company has developed an arm sleeve that reduces the risk of ulnar collateral ligament strain in basketball shooters. The product is currently undergoing evaluation to determine its suitability for use in physical therapy.

This basketball arm sleeve is designed for players and features a 3D motion sensor that captures data such as arm speed and shot count, then transmits the collected data to a mobile app. Coaches and team managers can access this player data through the application. The data gathered from users of this arm sleeve can reflect changes in their physical condition, such as muscle degeneration.

This wearable device is also widely used among tennis players, soccer players, and golfers. Currently, TheMotus Global is developing another arm sleeve suitable for general consumers, which is expected to hit the market this year.

CarePredict
This health technology company has produced a behavioral monitoring device called “Tempo.” This wearable medical device, designed in the form of a watch, is specifically tailored for the elderly. It helps them monitor daily activities and behavioral patterns, recording these in a “Rhythm Diary.” Once these activities and patterns are logged, any changes in real-life circumstances will trigger alerts to the seniors’ family and friends.

CEO Satish Movva stated, “This device can provide a more accurate interpretation of health status by combining data from daily activities with the locations where those activities occur.”

Hexoskin
Hexoskin has developed a vest that monitors the wearer’s health by recording heart rate, respiratory rate, and movement. This sensor-embedded vest has been utilized by Canadian Olympic athletes, space agencies, and military organizations.

Squash player Camille Serme. Source: Hexoskin

ZOLL Medical
The wearable medical device developed by ZOLL, named Life Vest, is specifically designed for patients with heart disease, a population estimated to number approximately 920,000.

According to the official website, the Life Vest wearable cardioverter defibrillator is designed for patients at risk of sudden cardiac arrest. It provides protection when the patient’s condition changes or when they face a risk of sudden cardiac arrest. It also buys physicians sufficient time to assess the patient’s long-term arrhythmia risk and develop an appropriate treatment plan.

Compiled by Zi Junwei | Edited by Mo Renying